Registration extended for 10th workshop on Innovative Mouse Models (IMM2019) – 19th to 21st June, 2019 in Leiden, The Netherlands.

Between the 19th and 21st of June 2019, the Netherlands Cancer Institute (NKI) and the Leiden University Medical Center (LUMC) organise the 10th edition of the workshop on Innovative Mouse Models (IMM2019) in Leiden, the Netherlands.

The goal of IMM2019 is to bring together a diverse group of scientists interested in all aspects of advanced mouse experiments within current ethical standards. Among the participants are key developers of emerging technologies as well as researchers who wish to apply and assess these new approaches. The workshop encourages an in-depth and unvarnished discussion of novel developments in a 3-day program with a series of invited speakers and presentations selected from submitted abstracts. IMM2019 is a unique opportunity for young researchers to share their experiences by means of a poster or brief oral presentation with a highly specialised audience.

The early-bird registration fee is: 200 € (DEADLINE EXTENDED: 13th May, 2019)

The late registration fee: 250 € (deadline: 19th May, 2019)

Abstract submission closes on the 19th May, 2019

For more information, visit:

To register, click here: IMM2019 Registration

The topics to be discussed at this edition include:

How to make genetically-engineered mice in the CRISPR/Cas9 era?

Novel in vivo applications of CRISPR/Cas9 technology

Advanced imaging and phenotyping

How to deal with the mouse microbiota?

Closing debate: the future of mouse models in fundamental and/or translational research

Invited speakers include:

Hellmut Augustin (Deutsches Krebsforschungszentrum, Heidelberg)

Lukas Dow (Weill Cornell Medicine, New York)

Mark Henkelman (Mouse Imaging Centre, Toronto)

Yann Herault (Institut Génétique Biologie Moléculaire Cellulaire, Illkirch)

Floor Hugenholtz (Microbiota Center Amsterdam, Amsterdam)

Ivo Huijbers (The Netherlands Cancer Institute, Amsterdam)

Reza Kalhor (Harvard Medical School, Boston)

Arthur Liesz (University Medical Center Munich, Munich)

Jacco van Rheenen (The Netherlands Cancer Institute, Amsterdam)

Els Robanus-Maandag (Leiden University Medical Centre, Leiden)

Christine Mummery (Leiden University Medical Centre, Leiden)

Mihail Todorov (Ludwig Maximilian University of Munich, Munich)

Søren Warming (Genentech, South San Francisco)

Branko Zevnik (CECAD Cologne, Cologne)